352 related articles for article (PubMed ID: 32732334)
1. Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging.
Sullivan FM; Mair FS; Anderson W; Armory P; Briggs A; Chew C; Dorward A; Haughney J; Hogarth F; Kendrick D; Littleford R; McConnachie A; McCowan C; McMeekin N; Patel M; Rauchhaus P; Ritchie L; Robertson C; Robertson J; Robles-Zurita J; Sarvesvaran J; Sewell H; Sproule M; Taylor T; Tello A; Treweek S; Vedhara K; Schembri S;
Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32732334
[TBL] [Abstract][Full Text] [Related]
2. Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial.
Sullivan FM; Farmer E; Mair FS; Treweek S; Kendrick D; Jackson C; Robertson C; Briggs A; McCowan C; Bedford L; Young B; Vedhara K; Gallant S; Littleford R; Robertson J; Sewell H; Dorward A; Sarvesvaran J; Schembri S
BMC Cancer; 2017 Mar; 17(1):187. PubMed ID: 28284200
[TBL] [Abstract][Full Text] [Related]
3. EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation.
Duarte A; Corbett M; Melton H; Harden M; Palmer S; Soares M; Simmonds M
Health Technol Assess; 2022 Dec; 26(49):1-184. PubMed ID: 36534989
[TBL] [Abstract][Full Text] [Related]
4. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
5. Performance of the EarlyCDT® Lung test in detection of lung cancer and pulmonary metastases in a high-risk cohort.
Borg M; Wen SWC; Nederby L; Hansen TF; Jakobsen A; Andersen RF; Weinreich UM; Hilberg O
Lung Cancer; 2021 Aug; 158():85-90. PubMed ID: 34130044
[TBL] [Abstract][Full Text] [Related]
6. Audit of the autoantibody test, EarlyCDT®-lung, in 1600 patients: an evaluation of its performance in routine clinical practice.
Jett JR; Peek LJ; Fredericks L; Jewell W; Pingleton WW; Robertson JF
Lung Cancer; 2014 Jan; 83(1):51-5. PubMed ID: 24268382
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts.
Wu WY; Haider Z; Feng X; Heath AK; Tjønneland A; Agudo A; Masala G; Robbins HA; Huerta JM; Guevara M; Schulze MB; Rodriguez-Barranco M; Vineis P; Tumino R; Kaaks R; Fortner RT; Sieri S; Panico S; Nøst TH; Sandanger TM; Braaten T; Johansson M; Melin B; Johansson M
Int J Cancer; 2023 May; 152(9):2002-2010. PubMed ID: 36305647
[TBL] [Abstract][Full Text] [Related]
8. The effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial.
Parker A; Knapp P; Treweek S; Madhurasinghe V; Littleford R; Gallant S; Sullivan F; Schembri S; Rick J; Graffy J; Collier DJ; Eldridge S; Kennedy A; Bower P
Trials; 2018 Sep; 19(1):503. PubMed ID: 30227890
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules.
Edelsberg J; Weycker D; Atwood M; Hamilton-Fairley G; Jett JR
PLoS One; 2018; 13(5):e0197826. PubMed ID: 29787590
[TBL] [Abstract][Full Text] [Related]
10. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
[TBL] [Abstract][Full Text] [Related]
11. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
12. Can autoantibody tests enhance lung cancer screening?-an evaluation of EarlyCDT
González Maldonado S; Johnson T; Motsch E; Delorme S; Kaaks R
Transl Lung Cancer Res; 2021 Jan; 10(1):233-242. PubMed ID: 33569307
[TBL] [Abstract][Full Text] [Related]
13. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer.
Lam S; Boyle P; Healey GF; Maddison P; Peek L; Murray A; Chapman CJ; Allen J; Wood WC; Sewell HF; Robertson JF
Cancer Prev Res (Phila); 2011 Jul; 4(7):1126-34. PubMed ID: 21733826
[TBL] [Abstract][Full Text] [Related]
14. Application of a high throughput method of biomarker discovery to improvement of the EarlyCDT(®)-Lung Test.
Macdonald IK; Murray A; Healey GF; Parsy-Kowalska CB; Allen J; McElveen J; Robertson C; Sewell HF; Chapman CJ; Robertson JF
PLoS One; 2012; 7(12):e51002. PubMed ID: 23272083
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of a new autoantibody test added to Computed Tomography (CT) compared to CT surveillance alone in the diagnosis of lung cancer amongst patients with indeterminate pulmonary nodules.
Sutton AJ; Sagoo GS; Jackson L; Fisher M; Hamilton-Fairley G; Murray A; Hill A
PLoS One; 2020; 15(9):e0237492. PubMed ID: 32877432
[TBL] [Abstract][Full Text] [Related]
16. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
[TBL] [Abstract][Full Text] [Related]
18. Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group.
Spiro SG; Shah PL; Rintoul RC; George J; Janes S; Callister M; Novelli M; Shaw P; Kocjan G; Griffiths C; Falzon M; Booton R; Magee N; Peake M; Dhillon P; Sridharan K; Nicholson AG; Padley S; Taylor MN; Ahmed A; Allen J; Ngai Y; Chinyanganya N; Ashford-Turner V; Lewis S; Oukrif D; Rabbitts P; Counsell N; Hackshaw A
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31537697
[TBL] [Abstract][Full Text] [Related]
19. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Broderick C; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010837. PubMed ID: 30407621
[TBL] [Abstract][Full Text] [Related]
20. Survival Following Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial.
Gierada DS; Pinsky PF
Chest; 2021 Feb; 159(2):862-869. PubMed ID: 32822676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
